To identify BPC157-FBXO22-dependent effectors, we treated HUVECs with BPC157 for 24 h and analyzed protein expression via Western blotting
KPV reduces inflammation by inhibiting NF-kB signaling, one of the most studied inflammatory pathways in medicine, and is absorbed through a dedicated intestinal transporter called PepT1
However, the existing body of research suggests that Dihexa could be a promising tool in the treatment of cognitive disorders and neurodegenerative diseases
While larger human trials are ongoing, the science is increasingly pointing toward peptides as functional, body-aligned interventions in weight management
and counting down the hours until bedtime based on how much sleep you've had, you might attribute this daily struggle to overwork or insufficient sleep
The CAPTAIN trials used 50 mL daily for acute treatment and 10 mL daily for maintenance